Today's pharmaceutical & biotechnology companies face myriad challenges in trying to bring new drugs, therapies and technologies to those who need them. Timing is crucial in determining which companies are successful in this extremely competitive industry. Selecting a development partner with a proven track record and a strong understanding of the entire product development life cycle is crucial in the success of the project. The intense competition and price sensitivity of the market is forcing the global giants to outsource manufacturing and focus on their core competencies. Companies can conserve cash by avoiding capital investments and eliminating long lead times to build, commission and validate a new manufacturing facility by taking advantage of our-state-of-the art- cGMP multi-purpose facility. Concord with its broad tool box of capabilities and technologies is able to enable the production of tailor made API’s for use as pharmaceuticals, biotherapeutics, nutraceuticals and animal health products.
Concord has initiated CRAM activities, for global giants in the area of strain improvement, biotransformation, secondary metabolites etc. We have completely integrated R&D, technology, engineering and regulatory complaint GMP manufacturing facilities with extensive expertise in every phase of the development process and across multiple therapeutic areas. This successful combination provides Concord’s customers an unmatched level of confidence and competitive advantage over the entire life cycle of their product.
Concord continues to explore strategic alliances with global giants and IP companies for their requirements related to fermentation based APIs in areas ranging from custom synthesis to manufacturing.
